Articles |
the Institute of Pharmacological Sciences, University of Milano (W.Z., P.R., A.P., A.L.C.), the Centro per lo Studio delle Vasculopatie Periferiche, Ospedale Bassini (A.L.C.), and the Cardiovascular Physiopathology Laboratory, Istituto Scientifico H. S. Raffaele (F.P.), Milano, Italy.
Correspondence to Prof Alberico L. Catapano, Institute of Pharmacological Sciences, Via Balzaretti, 9, 20133 Milano, Italy.
| Abstract |
|---|
|
|
|---|
Key Words: cytotoxicity proliferation stress response
| Introduction |
|---|
|
|
|---|
Oxidatively modified LDL exists in vivo and has been detected in blood vessel walls at sites of atherosclerotic lesions1 24 ; here focal changes in the expression of hsp70, with increased presence of immunoreactive hsp72/73 in the most involved areas, have also been described.25 26
We previously observed13 14 that the degree of confluence affects the sensitivity of endothelial and smooth muscle cells to OxLDL cytotoxicity and accordingly the expression of hsp70. With the present studies, we aimed at understanding which factors modulate hsp70 expression by analyzing the effect of different experimental conditions in sparse endothelial cells and by directly comparing the response of cocultured sparse and confluent cells to a challenge with OxLDL.
| Methods |
|---|
|
|
|---|
Lipoproteins
LDL (1.019 to 1.063 g/mL) was isolated from human plasma by preparative ultracentrifugation29 and dialyzed in 0.15 mol/L NaCl, 0.01% EDTA. Just before oxidation, EDTA was removed by gel filtration in PBS on a Sephadex G-25 column (PD-10, Pharmacia). Protein was measured by the method of Lowry et al.30 LDL (200 µg lipoprotein protein per milliliter) was oxidized in sterile conditions for 24 hours at 37°C in PBS containing CuSO4 (20 µmol/L), concentrated by ultrafiltration under N2 pressure in an Amicon ultrafiltration apparatus fitted with a YM 100 membrane (American Corporation), desalted in PBS on Sephadex G-25 columns (PD-10), and sterile filtered. LDL modification was assessed by nondenaturing gel electrophoresis in 0.8% agarose (Agarose A, Pharmacia) in 0.1 mol/L Tris, pH 8.6, at 200 V.31 According to the literature, electrophoretic mobility increased after oxidation and was slightly lower than that of acetylated LDL.
To test the influence of the interaction between receptors and protein ligands on hsp70 expression, aliquots of medium containing LDL or OxLDL were boiled for 15 minutes in sterile conditions. Lipids were extracted from LDL and OxLDL with chloroform/methanol 2:1 (vol/vol).32 Extracts were evaporated to dryness under an N2 stream, and lipids were redissolved in absolute ethanol. The solution was filtered through a 0.45-µm pore filter to decrease turbidity, and aliquots were added to the incubation medium. The volume of ethanol never exceeded 1% of total medium volume. Control medium containing 1% ethanol did not affect cell viability or hsp70 expression.
Cell Viability
Cell viability was assessed by the release of [3H]adenine into the culture medium.33 Cells were labeled for 1 hour with [3H]adenine (1 µCi/mL medium), washed twice, and incubated for 24 hours at 37°C in medium containing LDL or OxLDL (200 µg/mL). The medium was collected and the cells were dissolved in 1 N NaOH. Aliquots of the medium and of solubilized cells were counted and percent [3H]adenine release was expressed as the ratio of medium radioactivity to medium plus cell radioactivity.
[3H]Thymidine Labeling
Cells were washed with PBS and incubated for 1 hour in MEM containing [3H]thymidine (2 µCi/mL). Cells were then washed three times in PBS, incubated with 5% trichloroacetic acid (10 minutes), and washed twice in 5% trichloroacetic acid; 1 mL of 1 N NaOH was added to each well. Aliquots were used to measure protein and radioactivity content.
Uptake and Degradation of Iodinated Lipoproteins
Lipoproteins were labeled with [125I]NaI according to Bilheimer et al,34 desalted by gel filtration on Sephadex G-25 eluted with PBS, and sterile filtered. Specific activity was 200 to 400 cpm/ng lipoprotein protein. EAhy-926 cells were incubated for 6 hours at 37°C in MEM containing essential fatty acidfree BSA (2 mg/mL) and 125I-OxLDL or in the same medium containing, in addition to 125I-OxLDL, an excess (30-fold) of unlabeled lipoprotein. Specific uptake was calculated as the difference between uptake by cells incubated without and with unlabeled OxLDL.35 Specific degradation was calculated as the difference between degradation of 125I-OxLDL incubated in the presence and absence of cells.35
Uptake was also measured in cells incubated with 125I-OxLDL in the presence of fucoidin (20 µg/mL), which binds to scavenger receptors with high affinity.
Immunocytochemistry
Sparse or confluent cultures were incubated with OxLDL (400 µg/mL) for different time periods (up to 24 hours) or with different concentrations (200 to 800 µg/mL) of the modified lipoprotein. Cells were fixed in 3% paraformaldehyde in 150 mmol/L NaCl, 10 mmol/L Tris, and 2% sucrose, pH 7.5 (3% paraformaldehyde solution) (15 minutes at room temperature) and processed for immunostaining as described previously.13 Antibodies used were (1) mouse monoclonal antibody specific for hsp72, the inducible form of hsp70 (C92F3A-5, Stressgen, 1:200), followed by biotinylated anti-mouse IgG (Amersham, 1:250) and fluorescein-conjugated streptavidin (Amersham, 1:200); (2) mouse monoclonal antibody against BrdU (BUI/75-ICR 1, Sera-Lab, 1:50), followed by rhodamine-conjugated anti-mouse IgG (Amersham, 1:200); (3) mouse monoclonal antibody against OxLDL, obtained in our laboratory, followed by biotinylated anti-mouse IgG (1:100) and fluorescein-conjugated streptavidin (1:200). Stain specificity was assessed by omitting either the first or second antibody. For double labeling, the following steps were performed after staining for hsp70: a wash in PBST, fixation in 0.5% paraformaldehyde solution (30 minutes at 4°C and 30 minutes at room temperature), a wash in PBST, incubation in 2 N HCl+0.5% Tween 20 (10 minutes at 37°C), a wash in 0.1 mol/L Na2B4O7 (pH 8.5), and a wash with PBST. Staining for BrdU was then performed. Coverslips were mounted on microscopy slides with glycerol/PBS 1:1 (vol/vol), examined with a Zeiss Axioscop fluorescence microscope (filter sets: BP 450-490, FT 510, LP 520 for fluorescein; BP 546, FT 580, LP 590 for rhodamine), and photographed using 400 ASA Diachrome film.
The expression of hsp70 was also assessed in cells incubated with OxLDL (400 µg/mL) in the presence of fucoidin (20 µg/mL) or of chloroquine (50 µmol/L), as well as in cells incubated with total lipids extracted from LDL or OxLDL.
To evaluate, within the same culture plate, the response of sparse and confluent cells to a challenge with OxLDL, a wounding experiment was performed. HUVECs were cultured to a postconfluent state, as judged on the basis of their cobblestone morphology; the monolayer was then wounded with a polytetrafluoroethylene cell lifter and the cells were allowed to recover for 24 hours in M-199 containing FCS (20%). After recovery, BrdU (10 µmol/L final concentration) was added to the culture medium for a further incubation of 6 hours. The medium was then replaced by M-199 containing OxLDL (400 to 600 µg/mL) for a period of 12 hours. At the end of the incubation, cells were processed for immunostaining of hsp70 and BrdU.36
Immunoblotting
Sparse or confluent cultures were incubated with OxLDL for different time periods (up to 24 hours) or with different concentrations (200 to 800 µg/mL) of the modified lipoprotein.
Cells were lysed in Tris-glycine buffer (0.25 mol/L Tris, 0.173 mol/L glycine, pH 8.5) containing SDS (3%), and protein was measured by the method of Lowry et al.30 Equal amounts of protein from the different samples were subjected to SDS-PAGE on a 10% polyacrylamide gel,37 after the addition of ß-mercaptoethanol (2%), glycerol, and bromophenol blue. Electrophoresed proteins were transferred onto a nitrocellulose membrane using a Trans Blot Cell (Bio-Rad).38 The membrane was incubated with a 1:1500 dilution of anti-hsp70 antibody (see above), then with a 1:2000 dilution of peroxidase-conjugated goat anti-mouse IgG (Amersham). Immunocomplexes were detected by an enhanced chemiluminescence method (ECL, Amersham), followed by autoradiography. Immunocomplexes were quantified by the Image program (ISF 1.47). Data were expressed as area units.
Metabolic Labeling
Sparse cells were incubated in M-199 containing OxLDL (600 µg/mL and 800 µg/mL) for 6 hours or heat shocked at 45°C for 15 minutes and allowed to recover for 2 hours in fresh M-199 containing 20% FCS. During the last hour of incubation a [35S]protein-labeling mixture (EXPRE35S Protein Mix, Du Pont-NEN, >1000 Ci/mmol, containing >77% L[-35S]methionine and 18% L-[35S]cysteine) was added to the medium (50 µCi/mL). Cells were washed three times in PBS and lysed in sample buffer (3% SDS, 10% ß-mercaptoethanol, 2% glycerol, and bromophenol blue in Tris-glycine buffer, pH 8.5). The content of radioactivity was evaluated in a beta counter and equal numbers of counts were loaded onto a 10% polyacrylamide gel for SDS-PAGE. Gels were dried and processed for autoradiography.
| Results |
|---|
|
|
|---|
|
|
Different scavenger receptors mediate the specific binding and internalization of OxLDL. We therefore speculated that if the response elicited by OxLDL required the internalization of the lipoprotein, different degrees of expression of scavenger receptors in sparse and confluent cells might explain our findings; however, specific uptake and degradation of 125I-OxLDL by sparse EAhy-926 cells were similar to those measured with confluent cells per milligram of cell protein (Fig 3A and 3B![]()
). These data agreed with the results of immunostaining with anti-OxLDL, which showed similar amounts of internalized OxLDL in sparse and confluent HUVECs (not shown). The role of receptor-mediated internalization and degradation of OxLDL in the stress response activated by this lipoprotein (Fig 4
; compare panels a and b for the effects of OxLDL and LDL) was assessed by immunofluorescence. Fucoidin did not hamper the expression of hsp70 triggered by these lipoproteins (panel c), although it competed with OxLDL for uptake via scavenger receptors. In fact, in the presence of fucoidin (20 µg/mL), uptake of 125I-OxLDL decreased from 322±22 to 144±10 ng/mg cell protein in sparse EAhy-926 cells and from 342±36 to 98±8 ng/mg cell protein in confluent cells (mean±SD of triplicate experiments). Fucoidin alone did not trigger hsp70 expression (panel d). Similarly, blocking lysosomal degradation of OxLDL with chloroquine did not prevent hsp70 expression (panel e), while chloroquine alone did not induce its expression (panel f). Heat-denatured OxLDL, which lost its ability to interact with receptors, still induced hsp70 expression (panel g), while heat-denatured LDL was ineffective (panel h). Lipids extracted from OxLDL strongly induced hsp70 expression (panel i), while lipids extracted from native LDL did not (panel j). All together, these data support the conclusion that the activity of scavenger receptors and lipoprotein internalization and degradation are not determinants of the induction of hsp70 expression.
|
|
Since the degree of confluence does not affect the expression of OxLDL receptors and their activity is not critical for the stress response, we wondered what factor peculiar to confluent cells might render them relatively resistant to OxLDL. We therefore tested the possibility that endothelial cells secrete factors protecting against OxLDL toxicity: in such case, only a large number of juxtaposed cells could potentially yield an effective concentration of cytoprotective agents. Sparse HUVECs were incubated with OxLDL (200 µg/mL) in conditioned media collected from sparse and confluent cultures. Because hsp70 expression was induced in both conditions in HUVECs (Fig 5
, panels a and b) as well as in the EAhy-926 line (panels c and d), we concluded that the relative resistance of confluent cells to OxLDL does not depend on reaching a threshold concentration of a putative cytoprotective factor.
|
Besides soluble factors, cells produce insoluble extracellular matrix components, which can influence their response to stress.39 Cells sparsely grown on different culture substrates, such as polylysine, fibronectin, or gelatin, or on uncoated culture dishes were equally sensitive to OxLDL (Fig 5
, panels e through h); therefore, neither the type nor amount of extracellular matrix, presumably more abundant in confluent cultures, can explain the relative resistance to OxLDL.
One major difference between sparse and confluent cells may be that the former are proliferating (ie, proceeding through the cell cycle) or migrating on the culture surface, while the latter are in a relatively quiescent state. Indeed, in our culture conditions, the incorporation of [3H]thymidine by sparse cells was usually more than six times that measured in confluent cells (not shown). We therefore designed an experiment that allowed us to compare, within the same culture plate, the response of proliferating/migrating and quiescent cells to a challenge with OxLDL. After wounding a confluent monolayer, we allowed enough time for the cells closest to the lesion to start healing it by proliferating and/or migrating. Cells were then incubated with a cytotoxic concentration of OxLDL known to markedly inhibit proliferation and induce hsp70 expression. Fig 6
depicts the immunostaining results. Cells located on the edge of the wound expressed hsp70, while those not involved in the repair process displayed a faint background staining (panel a). When BrdU, a thymidine analogue, was used to label cycling cells during wound repair, the majority of cells were positive for both hsp70 (panel b) and BrdU (panel c); this indicated that cells on the edge of the injured area expressed hsp70 (panels b and d) on challenge with OxLDL and were actively cycling (panels c and d). In fact, since recovery took place in serum-containing medium, healing of the wound monolayer was most likely due to cell proliferation. Immunostaining with antiproliferating cell nuclear antigen (a marker of cell growth) showed a strong nuclear staining in cells on the edge of the injury, indicating that the majority of them were actively proliferating (not shown). Immunostaining of a wounded monolayer that was allowed to recover and then incubated in complete medium without OxLDL was negative, indicating that injury and recovery per se were not able to induce the expression of hsp70 in cells on the edge of the lesion.
|
| Discussion |
|---|
|
|
|---|
The expression of hsp70 mostly depended on whether cells exposed to OxLDL were in a postconfluent or in a nonconfluent state; that is, whether they were quiescent or proceeding through the cell cycle. This was clear when a monolayer of endothelial cells displaying the cobblestone morphology was mechanically wounded and then allowed to recover. Only the cells at the edge of the wound, which were proliferating and most probably responsible for healing the lesion, expressed hsp70 on incubation with OxLDL. Omission of ECGF from incubation medium did not affect the expression of hsp70 in injured cells exposed to OxLDL, suggesting that hsp70 induction by OxLDL is not dependent on the presence of growth factors (not shown). The noncomplete colocalization of induced hsp70 and of BrdU (see "Results") may indicate the presence of migrating cells or of a small number of cells that, although proliferating, did not incorporate BrdU. In fact, we cannot rule out the possibility that the time allowed for BrdU incorporation was not sufficient to label every cycling cell. Since not only proliferating but also migrating cells may be involved in wound repair, we cannot exclude the possibility that the latter are also more sensitive than stationary cells of a contact-inhibited monolayer to the toxicity of OxLDL. However, the vast majority of the cells expressing hsp70 were also labeled with BrdU, suggesting a close relation between cell cycle and hsp70 expression driven by OxLDL. Cell-cycle dependence of hsp70 expression has been observed in heat-shocked Chinese hamster ovary cells.45 It appears that the induction of hsp72 is essential for the accomplishment of the early S phase and is also necessary in G1.45 Furthermore, OxLDL toxicity to fibroblasts appears to be selective for the S phase of the cell cycle.8
Regulation of endothelial cell proliferation in vivo is tightly controlled. Under normal conditions, these cells are quiescent and form an antithrombogenic monolayer. Different types of injury to the endothelial monolayer can result in endothelial activation or denudation and in adhesion of platelets to the subendothelium. Both the activated endothelium and the subendothelium may provide the source of growth factors for cell proliferation and rapid healing of the injured site.46 Lesion-prone areas of the vasculature are characterized by enhanced endothelial regeneration, probably reflecting repeated injury to the intima.47 These areas also show an increased permeability, which allows the diffusion of plasma lipoproteins into the subendothelial space and their subsequent oxidation. Therefore, in vivo, the risk of being challenged by OxLDL is higher for cells healing an injured vessel wall than for cells of unaffected areas. On the basis of the results obtained in vitro we speculate that, besides being disruptive for the structure and functionality of the arterial tissue, the cytotoxicity of OxLDL might also trigger the synthesis of hsps in the cells that are most sensitive to their toxicity. The stress response (namely, the expression of the inducible form of hsp70) may represent a defense mechanism against cytotoxic proatherogenic stimuli. Cytoprotection afforded by stress proteins may allow these healing cells a higher chance of surviving further cytotoxic challenges by factors other than the presence of oxidized lipoproteins. In step with the cytoprotective role of hsp70 are the observations that overexpression of hsp70 in transfected cells and in transgenic animals are associated with improved postischemic performance.22 48 Also, overexpression of hsp70 has been shown to increase the threshold for the release of stress mediators (IL-1, IL-6) induced by UV light and oxidants.49 It is of interest, however, that the induction of hsp70 expression in hypertensive animals presents a form of tolerance; ie, chronic hypertension does not induce hsp70 expression, while an acute increase of blood pressure does.50 If this is a general mechanism, it can be speculated that at early stages of atherosclerosis, hsp expression allows cells to cope with oxidative damage, while repeated oxidative insults will result in a lower ability to cope with them and eventually lead to cell death. Sustained hsp70 expression may then result in protection from chronic damage, and work is in progress to address this issue in cells overexpressing inducible hsp70.
In summary, we have demonstrated that OxLDL can trigger the expression of hsp70 (inducible form) only in nonconfluent endothelial cells and that cell proliferation is responsible for this expression. Whether this effect has in vivo relevance remains to be addressed; we speculate that cells rapidly growing are more sensitive to cytotoxicity of OxLDL and that expression of hsp70 could allow a better chance of survival. Confirmation of this observation might have therapeutic applications in atherosclerosis.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received November 27, 1995;
revision received February 20, 1996;
| References |
|---|
|
|
|---|
2. Witztum JL, Steinberg D. Role of oxidized low density lipoproteins in atherogenesis. J Clin Invest. 1991;88:1785-1792.
3.
Sparrow CP, Parthasarathy S, Steinberg DA. A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. J Biol Chem. 1989;264:2599-2604.
4.
Endemann G, Stanton LW, Madden KS, Bryant CM, Whit RT, Protter AA. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem. 1993;268:11811-11816.
5.
Ottnad E, Parthasarathy S, Sambrano GR, Ramprasad MR, Quehenberger O, Konratenko N, Green S, Steinberg D. A macrophage receptor for oxidized low density lipoprotein distinct from the receptor for acetyl low density lipoprotein: partial purification and role in recognition of oxidatively damaged cells. Proc Natl Acad Sci U S A. 1995;92:1391-1395.
6. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dependent arterial relaxation by lysolecithin modified low-density lipoproteins. Nature. 1990;344:160-162.[Medline] [Order article via Infotrieve]
7.
Hessler JR, Morel DW, Lewis LJ, Chisolm GM. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis. 1983;3:215-222.
8. Kosugi K, Diane WM, Morel DW, Di Corleto PE; Chisolm GM. Toxicity of oxidized low-density lipoprotein to cultured fibroblasts is selective for S phase of the cell cycle. J Cell Physiol. 1987;130:311-320.[Medline] [Order article via Infotrieve]
9.
Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz CJ, Fogelman AM. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A. 1990;87:5134-5138.
10. Lehr HA, Olofsson AM, Carew TE, Vajkoczy P, von Andrian UH, Hubner C, Berndt MC, Steinberg D, Messmer K, Arfors KE. P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo. Lab Invest. 1994;71:380-386.[Medline] [Order article via Infotrieve]
11. Kume N, Cybulsky MI, Gimbrone MA. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest. 1992;90:1138-1144.
12. Yamaguchi M, Sato I, Bannai S. Induction of stress protein in mouse peritoneal macrophages by oxidized low density lipoprotein. Biochem Biophys Res Commun. 1993;193:1198-1201.[Medline] [Order article via Infotrieve]
13. Zhu WM, Roma P, Pellegatta F, Catapano AL. Oxidized low density lipoproteins induce the expression of heat shock protein 70 in human endothelial cells. Biochem Biophys Res Commun. 1994;200:389-394.[Medline] [Order article via Infotrieve]
14. Zhu WM, Roma P, Pirillo A, Pellegatta F, Catapano AL. Oxidized LDL induce hsp70 expression of heat shock protein 70 in human smooth muscle cells. FEBS Lett. 1995;372:1-5.[Medline] [Order article via Infotrieve]
15.
Ang D, Liberek C, Skowyra D, Zylicz M, Georgopulos C. Function and regulation of the universally conserved heat shock proteins. J Biol Chem. 1991;266:24233-24236.
16.
Welch WJ. Mammalian stress response: cell physiology, structure/function of stress proteins and implications for medicine and disease. Physiol Rev. 1992;72:1063-1081.
17. Georgopulos C, Welch WJ. Role of the major heat shock proteins as molecular chaperones. Annu Rev Cell Biol. 1993;9:601-634.
18. Hendrick JP, Hartl FU. Molecular chaperone functions of heat-shock proteins. Annu Rev Biochem. 1993;62:349-384.[Medline] [Order article via Infotrieve]
19. Chirico W, Waters M, Blobel G. 70K heat shock related proteins stimulate protein translocation into microsomes. Nature. 1988;332:805-810.[Medline] [Order article via Infotrieve]
20. Minowada G, Welch WJ. Clinical implications of the stress response. J Clin Invest. 1995;95:3-12.
21. Jacquier-Sarlin MR, Fuller K, Dinh-Xuan AT, Richard MJ, Polla BS. Protective effects of hsp70 in inflammation. Experientia. 1994;50:1031-1038.[Medline] [Order article via Infotrieve]
22. Marber MS, Mestril R, Chi SH, Sayen MR, Yellon DM, Dillmann WH. Overexpression of rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemia injury. J Clin Invest. 1995;95:1446-1456.
23.
Currie RW, Tanguay RM, Kingma JG Jr. Heat shock response and limitation of tissue necrosis during occlusion/reperfusion in rabbit hearts. Circulation. 1992;87:963-971.
24. Yla-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989;84:1086-1095.
25. Berberian PA, Myers W, Tytell M, Challa V, Bond G. Immunohistochemical localization of heat shock protein-70 in normal-appearing and atherosclerotic specimens of human arteries. Am J Pathol. 1990;136:71-80.[Abstract]
26. Johnson AD, Berberian PA, Tytell M, Bond G. Atherosclerosis alters the localization of hsp70 in human and macaque aortas. Exp Mol Pathol. 1993;58:155-168.[Medline] [Order article via Infotrieve]
27. Jaffe EA, Nachman RL, Becker CJ, Minick CR. Culture of human endothelial cells derived from umbilical veins: identification by morphological and immunological criteria. J Clin Invest. 1973;52:2745-2749.
28.
Edgell CJS, Mc Donald CC, Graham JB. Permanent cell line expressing human factor VIIIrelated antigen established by hybridization. Proc Natl Acad Sci U S A. 1983;80:3734-3737.
29. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955;34:1345-1353.
30.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
31. Noble RP. Electrophoretic separation of plasma lipoproteins in agarose gels. J Lipid Res. 1968;9:693-700.[Abstract]
32. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1951;37:911-917.
33. Kishi Y, Numano F. In vitro study of vascular endothelial injury by activated platelets and its prevention. Atherosclerosis. 1989;76:95-101.[Medline] [Order article via Infotrieve]
34. Bilheimer DW, Eisenberg S, Levy RI. The metabolism of very low density lipoprotein proteins, I: preliminary in vitro and in vivo observations. Biochim Biophys Acta. 1973;250:212-221.
35.
Goldstein JL. Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediate the uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A. 1979;76:333-337.
36. Houck DW, Loken MR. Simultaneous analysis of cell surface antigens, bromodeoxyuridine incorporation and DNA content. Cytometry. 1993;6:531-538.
37. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.[Medline] [Order article via Infotrieve]
38.
Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979;76:4350-4354.
39. Ketis NV, Lawler J, Bendena WG. Extracellular matrix components affect the pattern of protein synthesis of endothelial cells responding to hyperthermia. In Vitro Cell Dev Biol. 1993;29A:768-772.
40. Zhang HF, Basra HJK, Steinbrecher UP. Effects of oxidatively modified LDL on cholesterol esterification in cultured macrophages. J Lipid Res. 1990;31:1361-1369.[Abstract]
41. Malavasi B, Rasetti MF, Roma P, Fogliatto R, Allevi P, Catapano AL, Galli G. Evidence for the presence of 7-hydroperoxycholest-5-en-3ß-ol in oxidized human LDL. Chem Phys Lipids. 1992;62:209-214.[Medline] [Order article via Infotrieve]
42.
Pettersen KS, Boberg KM, Stabursvik A, Prydr H. Toxicity of oxygenated cholesterol derivatives toward cultured human umbilical vein endothelial cells. Arterioscler Thromb. 1991;11:423-428.
43. Ramasamy S, Boissonneault GA, Hennig B. Oxysterol-induced endothelial cell dysfunction in culture. J Am Coll Nutr. 1992;11:532-538.[Abstract]
44. Cajone F, Salina M, Benelli-Zazzera A. 4-Hydroxynonenal induces a DNA-binding protein similar to the heat-shock factor. Biochem J. 1989;262:977-979.[Medline] [Order article via Infotrieve]
45. Hang H, Fox MH. Expression of hsp70 induced in CHO cells by 45.0°C hyperthermia is cell cycle associated and DNA synthesis dependent. Cytometry. 1995;19:119-125.[Medline] [Order article via Infotrieve]
46. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.[Medline] [Order article via Infotrieve]
47. Caplan BA, Schwartz CJ. Increased endothelial cell turnover in areas of in vivo Evans blue uptake in the pig aorta. Atherosclerosis. 1973;17:401-417.[Medline] [Order article via Infotrieve]
48. Mestril R, Chi SH, Sayen MR, O'Reilly K, Dillmann WH. Expression of inducible stress protein 70 in rat heart myogenic cells confers protection against simulated ischemia-induced injury. J Clin Invest. 1994;93:759-767.
49. Simon MM, Reikerstorfer A, Schwarz A, Krone C, Luger TA, Jaattela M, Schwarz T. Heat shock protein 70 overexpression affects the response to ultraviolet light in murine fibroblasts: evidence for increased cell viability and suppression of cytokine release. J Clin Invest. 1995;95:926-933.
50.
Xu Q, Li D, Holbrook J, Udelsman R. Acute hypertension induces heat-shock protein 70 gene expression in rat aorta. Circulation. 1995;92:1223-1229.
This article has been cited by other articles:
![]() |
G.H.M. van Puijvelde, T. van Es, E.J.A. van Wanrooij, K.L.L. Habets, P. de Vos, R. van der Zee, W. van Eden, Th. J.C. van Berkel, and J. Kuiper Induction of Oral Tolerance to HSP60 or an HSP60-Peptide Activates T Cell Regulation and Reduces Atherosclerosis Arterioscler Thromb Vasc Biol, December 1, 2007; 27(12): 2677 - 2683. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zhao and G. X. Shen Involvement of Heat Shock Factor-1 in Glycated LDL-Induced Upregulation of Plasminogen Activator Inhibitor-1 in Vascular Endothelial Cells Diabetes, May 1, 2007; 56(5): 1436 - 1444. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. O. Apostolov, A. G. Basnakian, X. Yin, E. Ok, and S. V. Shah Modified LDLs induce proliferation-mediated death of human vascular endothelial cells through MAPK pathway Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1836 - H1846. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zal, J. C. Kaski, G. Arno, J. P. Akiyu, Q. Xu, D. Cole, M. Whelan, N. Russell, J. A. Madrigal, I. A. Dodi, et al. Heat-Shock Protein 60-Reactive CD4+CD28null T Cells in Patients With Acute Coronary Syndromes Circulation, March 16, 2004; 109(10): 1230 - 1235. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Mawji, G. B. Robb, S. C. Tai, and P. A. Marsden Role of the 3'-Untranslated Region of Human Endothelin-1 in Vascular Endothelial Cells: CONTRIBUTION TO TRANSCRIPT LABILITY AND THE CELLULAR HEAT SHOCK RESPONSE J. Biol. Chem., March 5, 2004; 279(10): 8655 - 8667. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Xu Role of Heat Shock Proteins in Atherosclerosis Arterioscler Thromb Vasc Biol, October 1, 2002; 22(10): 1547 - 1559. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Berco and B. R. Bhavnani Differential Neuroprotective Effects of Equine Estrogens Against Oxidized Low Density Lipoprotein--Induced Neuronal Cell Death Reproductive Sciences, July 1, 2001; 8(4): 245 - 254. [Abstract] [PDF] |
||||
![]() |
A. Pirillo, G. D. Norata, T. Zanelli, and A. L. Catapano Overexpression of Inducible Heat Shock Protein 70 in COS-1 Cells Fails to Protect From Cytotoxicity of Oxidized LDLs Arterioscler Thromb Vasc Biol, March 1, 2001; 21(3): 348 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. VASILE, Y. TOMITA, L. F. BROWN, O. KOCHER, and H. F. DVORAK Differential expression of thymosin {beta}-10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis FASEB J, February 1, 2001; 15(2): 458 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Benjamin and D. R. McMillan Stress (Heat Shock) Proteins : Molecular Chaperones in Cardiovascular Biology and Disease Circ. Res., July 27, 1998; 83(2): 117 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-e. Chow, R.-s. Lee, S. H. Shih, and J.-k. Chen Oxidized LDL promotes vascular endothelial cell pinocytosis via a prooxidation mechanism FASEB J, July 1, 1998; 12(10): 823 - 830. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |